Longitudinal Comparison of Thyroxine Pharmacokinetics Between Pregnant and Nonpregnant Women: A Stable Isotope Study
Authors:
- Offie P PhD SoldinOSOffie P PhD Soldin
- Steven J SoldinSSSteven J Soldin
- Alexander A VinksAVAlexander A Vinks
- Islam YounisIYIslam Younis
- Helain J LandyHLHelain J Landy
- 1 December 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 32 (6) , 767-773
Abstract
The treatment of maternal hypothyroidism presents clinicians with a unique challenge, because dosing regimens previously developed and validated for nonpregnant women cannot be easily extrapolated to dosing in pregnancy. Thyroid hormone requirement increases by 20% to 40% early during pregnancy, persisting throughout gestation. Accordingly, women with treated hypothyroidism need to increase their levothyroxine dose to prevent maternal hypothyroidism and the associated impaired cognitive development and increased fetal mortality. We investigated the pharmacokinetic properties of levothyroxine during pregnancy through the use of a novel, traceable form of levothyroxine. The objective was to conduct a longitudinal study to determine whether levothyroxine pharmacokinetics differ in the pregnant versus nonpregnant state. We used a unique 13C-levothyroxine-tracer method to distinguish between endogenous and exogenous levothyroxine and studied the pharmacokinetics of a single oral dose of levothyroxine using tandem mass spectrometry. Moreover, we were able to detect single dose amounts of the drug, in picogram/mL concentrations. The area under the curve was 23.0 ng*h/mL in pregnancy and 14.8 ng*h/mL in nonpregnant women (P < 0.03) with median serum half-lives of 32.1 hours and 24.1 hours, respectively (P < 0.04). Further research involves the measurement of free thyroxine on these samples using tandem mass spectrometry. Future work should focus on the mechanisms responsible for the gestational differences in pharmacokinetics and whether these should necessitate dose schedule changes in pregnancy.Keywords
This publication has 30 references indexed in Scilit:
- Thyroid hormone testing by tandem mass spectrometryClinical Biochemistry, 2011
- Therapeutic Drug Monitoring During Pregnancy and Lactation: Thyroid Function Assessment in Pregnancy—Challenges and SolutionsTherapeutic Drug Monitoring, 2010
- Importance of Monocarboxylate Transporter 8 for the Blood-Brain Barrier-Dependent Availability of 3,5,3′-Triiodo-l-ThyronineEndocrinology, 2009
- Unresolved questions in managing hypothyroidism during pregnancyBMJ, 2007
- Tandem Mass Spectrometry Improves the Accuracy of Free Thyroxine Measurements During PregnancyThyroid®, 2007
- Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassaysClinica Chimica Acta, 2004
- Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the ChildNew England Journal of Medicine, 1999
- Thyroid Hormone Levels Affected by Time of Blood Sampling in Thyroxine-Treated PatientsThyroid®, 1993
- Variations in Serum Thyroxine Concentrations with Time after an Oral Replacement DoseClinical Nuclear Medicine, 1987
- Thyroid hormone concentrations after exogenous thyroxine.BMJ, 1984